Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Deep and Durable Responses with Selinexor, Daratumumab, and Dexamethasome (SDd) in Patients with Multiple Myeloma (MM) Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs: Results of Phase 1b Study of SDd

Blood (2018) 132 (Supplement 1): 599.

https://doi.org/10.1182/blood-2018-99-117201

Published: 2018

Journal Articles

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Bruno K L Duarte, Gabriela G Yamaguti Hayakawa, MD, Francisco A Ferreira, MD, Katia B B Pagnano, MD PhD, Erich Vinicius De Paula, MD PhD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 4651.

https://doi.org/10.1182/blood.V130.Suppl_1.4651.4651

Published: 2017

Journal Articles

Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia

Jeffrey P. Sharman, MD, Kathryn S. Kolibaba, MD, Jose Azar, MD, Rama Balaraman, MD, Roger M. Lyons, MD, Mitchell R. Smith, MD PhD, Esteban Abella-Dominicis, MD, Wei Ye, PhD, Wen Shi, MD PhD, Thomas Giever, DO, Andres Forero-Torres, MD

Blood (2017) 130 (Supplement 1): 832.

https://doi.org/10.1182/blood.V130.Suppl_1.832.832

Published: 2017

Journal Articles

A Phase 1b Study to Assess the Combination of Selinexor and Daratumumab in Patients with Relapsed / Refractory Multiple Myeloma Previously Exposed to Proteasome Inhibitors (PI) and Immunomodulatory Drugs (IMiDs)

Cristina J. Gasparetto, MD, Suzanne Lentzsch, MD PhD, Gary J Schiller, MD, William Bensinger, MD, Nizar J. Bahlis, MD, Heather J. Sutherland, MD PhD FRCPC, Darrell J White, MD, Michael Sebag, MD PhD, Rami Kotb, MD, Christopher P. Venner, MD, Richard LeBlanc, MDFRCPC, Christine I Chen, MD FRCP(C), Aldo Del Col, BSPharm, MBA, Michael G. Kauffman, MD PhD, Sharon Shacham, PhD MBA, Jacqueline Jeha, Jean-Richard Saint-Martin, Jatin Shah, MD, Brea C. Lipe, MD

Blood (2017) 130 (Supplement 1): 3100.

https://doi.org/10.1182/blood.V130.Suppl_1.3100.3100

Published: 2017

Journal Articles

ERG11 and ABC2 Overexpression but Not ERG11 Gene Mutations Are Involved in the Development of Itraconazole Resistance in Candida Krusei

Xiaoyuan He, Mingfeng Zhao, MDPhD, Jinyan Chen, Rimao Wu, PhD, Jianlei Zhang, Rui Cui, MDPhD, Yanyu Jiang, Jie Chen, Xiaoli Cao, Yi Xing, Juanxia Meng, Qi Deng, Tao Sui, MDPhD

Blood (2015) 126 (23): 4624.

https://doi.org/10.1182/blood.V126.23.4624.4624

Published: 2015

Journal Articles

Bortezomib Overcomes Usual Prognosis Factor in Patients with Multiple Myeloma (MM) Having High Dose Therapy (HDT)

Sophie Auger, MD, Philippe Quittet, MD, Salaheddine Bouhya, MD, Tarik Kanouni, MD, Pascal Latry, MD, Mattea Orsini, Jean-Francois Rossi, MD, PhD

Blood (2011) 118 (21): 3104.

https://doi.org/10.1182/blood.V118.21.3104.3104

Published: 2011

Journal Articles

SNP12 and SNP13 Variants of NOD2/CARD15 Gene of Donor and Recipient as Independent Risk Factors for Severe Intestinal and Pulmonary GVHD after Allogeneic Hematopoietic Stem Cell Transplantation.

Alexandra Holowiecka-Goral, MD, Jerzy Wojnar, MD,PhD, Sebastian Giebel, MD, Elzbieta Grudziecka, PhD, Malgorzata Oczko, PhD, Barbara Jarzab, Monika Sankowska, PhD

Blood (2006) 108 (11): 3242.

https://doi.org/10.1182/blood.V108.11.3242.3242

Published: 2006

Journal Articles

Same Day Dosing of Pegfilgrastim in Elderly Patients Receiving Fractionated Dose Chemotherapy.

Larry Y. Watt, PharmD, Istvan Redei, MD, Robert D. Levin, MD, Joel Granick, MD, Rakhshanda Neelam, MD, Robert E. Musick, RPh

Blood (2004) 104 (11): 2215.

https://doi.org/10.1182/blood.V104.11.2215.2215

Published: 2004

NARROW

Deep and Durable Responses with Selinexor, Daratumumab, and Dexamethasome (SDd) in Patients with Multiple Myeloma (MM) Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs: Results of Phase 1b Study of SDd

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia

A Phase 1b Study to Assess the Combination of Selinexor and Daratumumab in Patients with Relapsed / Refractory Multiple Myeloma Previously Exposed to Proteasome Inhibitors (PI) and Immunomodulatory Drugs (IMiDs)

ERG11 and ABC2 Overexpression but Not ERG11 Gene Mutations Are Involved in the Development of Itraconazole Resistance in Candida Krusei

Bortezomib Overcomes Usual Prognosis Factor in Patients with Multiple Myeloma (MM) Having High Dose Therapy (HDT)

SNP12 and SNP13 Variants of NOD2/CARD15 Gene of Donor and Recipient as Independent Risk Factors for Severe Intestinal and Pulmonary GVHD after Allogeneic Hematopoietic Stem Cell Transplantation.

Same Day Dosing of Pegfilgrastim in Elderly Patients Receiving Fractionated Dose Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only